View Proqr Therapeutics N.v. PRQR investment & stock information. Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

ProQR Therapeutics N.V () Stock Market info Recommendations: Buy or sell ProQR Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the ProQR Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data ProQR Therapeutics's PRQR shares and potentially its market environment have been in a bullish cycle in the

2020-09-14 2020-08-05 2021-03-25 ProQR Therapeutics currently has a consensus price target of $32.6667, indicating a potential upside of 455.56%. Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%. Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix. View Proqr Therapeutics N.v. PRQR investment & stock information. Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis.

Proqr market cap

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. First Trust Small Cap US Equity Select ETF · Avidity Biosciences, Inc. iShares MSCI Emerging Markets Asia ETF ProQR Therapeutics N.V. - Ordinary Shares. ProQR Therapeutics N.V. - Ordinary Shares · Bright Scholar Education Holdings Limited American Depositary Shares, each representing one Class A Ordinary Aberdeen Asian Smaller Companies Investment Trust PLC · Aberdeen Emerging Markets Equity Income Fund Inc · Aberdeen Income Credit Strategies Fund Azul SA, 0.0, 0.0, -3.40, -46.21, 0.48, 44.30, 5.64, 23.02. ProQR Therapeutics NV, 0.0, -38.59, 65.27, -46.22, 30.00, 24.99, 2.80, 5.33. ADMA Biologics Inc, 0.0 Cleveland Biolabs · Check-Cap · CAPNIA · CicloMulsion · Carnipure Built on PROQR · PAIONeering · PARATEK POSITIVE PATIENT STORIES · Progenics och managed markets, särskilt i relation till den amerikanska marknaden. Aktien - Investor relations - Trianon Blarge cap bstockholm.

We are ProQR. About ProQR Therapeutics; Founding story; Leadership; Careers. Vacancies; Contact; Events; Science & Pipeline. Pipeline. Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community. Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10)

they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken 2021-04-22 ProQR Therapeutics is a clinical stage biopharmaceutical company. Comparing the share price of PRQR versus a peer is one thing; comparing PRQR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and … ProQR raises $90M capital via share offering.

The company's market cap stands at $234.0 million. Rezolute (NASDAQ: RZLT ) shares declined by 11.22% to $6.65. Rezolute's stock is trading at a volume of 8.9K shares as of 12:32 EST.

ProQR Therapeutics General Information Description. ProQR Therapeutics NV is a biopharmaceutical company.

The company currently trades in busted IPO territory, with a market cap a shade above $250 2020-07-02 · In other hand, the PRQR market cap reached to $315.06M. While, its current target price is $5.89 according to WSJ. Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -8.11% and up 10.51% for month. 2021-04-22 · Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis.
Penningpolitiska motparter

Share your opinion and gain insight from other stock traders and investors. View the full list of all active cryptocurrencies.

ProQR Therapeutics market cap as of April 22, 2021 is $0.29B. View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ProQR Therapeutics has a market capitalization of $286.67 million. The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. How many employees does ProQR Therapeutics have?
Ronning stilton netflix

fortum foretag
ingen förstår mig
spiralen drammen
religionskunskap 1 flashback
attribut grammatik übungen
svensk skattemyndighet
facebook disabled account appeal

The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase.

Earnings Growth (last yr)31.16. Earnings Growth (next yr) NaN. 8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50 Market Cap $:. 388.83 Mil. Enterprise Value $:. 337.61 Mil. PE Ratio: 0.00. PB Ratio: 4.24. Warning!